Welcome to LookChem.com Sign In|Join Free

CAS

  • or
D-Alanine, (1R)-1-carboxyethyl ester (9CI) is a D-alanyl ester derived from the formal condensation of the alcoholic hydroxy group of (2R)-lactic acid with the carboxylic acid group of D-alanine. It is a chiral molecule with specific stereochemistry, which can be crucial for its biological activity and interactions.

136577-07-6

Post Buying Request

136577-07-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

136577-07-6 Usage

Uses

Used in Pharmaceutical Industry:
D-Alanine, (1R)-1-carboxyethyl ester (9CI) is used as a building block for the synthesis of various pharmaceutical compounds, particularly those targeting the bacterial cell wall. Its unique structure allows for the creation of novel antibiotics that can potentially overcome antibiotic resistance in certain bacteria.
Used in Research and Development:
In the field of research and development, D-Alanine, (1R)-1-carboxyethyl ester (9CI) serves as an important compound for studying the role of D-amino acids in biological systems. It can be used to investigate the mechanisms of bacterial cell wall synthesis and to develop new strategies for targeting bacterial infections.
Used in Chemical Synthesis:
D-Alanine, (1R)-1-carboxyethyl ester (9CI) is also used as an intermediate in the synthesis of various chiral compounds, which find applications in the fields of pharmaceuticals, agrochemicals, and materials science. Its unique stereochemistry makes it a valuable starting material for the development of enantiomerically pure products.

Check Digit Verification of cas no

The CAS Registry Mumber 136577-07-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,5,7 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 136577-07:
(8*1)+(7*3)+(6*6)+(5*5)+(4*7)+(3*7)+(2*0)+(1*7)=146
146 % 10 = 6
So 136577-07-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H11NO4/c1-3(7)6(10)11-4(2)5(8)9/h3-4H,7H2,1-2H3,(H,8,9)/t3-,4-/m1/s1

136577-07-6Downstream Products

136577-07-6Relevant articles and documents

Synthesis of Lipid-Carbohydrate-Peptidyl-RNA Conjugates to Explore the Limits Imposed by the Substrate Specificity of Cell Wall Enzymes on the Acquisition of Drug Resistance

Fonvielle, Matthieu,Bouhss, Ahmed,Hoareau, Coralie,Patin, Delphine,Mengin-Lecreulx, Dominique,Iannazzo, Laura,Sakkas, Nicolas,El Sagheer, Affaf,Brown, Tom,Ethève-Quelquejeu, Mélanie,Arthur, Michel

, p. 14911 - 14915 (2018)

Conjugation of RNA with multiple partners to obtain mimics of complex biomolecules is limited by the identification of orthogonal reactions. Here, lipid-carbohydrate-peptidyl-RNA conjugates were obtained by post-functionalization reactions, solid-phase synthesis, and enzymatic steps, to generate molecules mimicking the substrates of FmhB, an essential peptidoglycan synthesis enzyme of Staphylococcus aureus. Mimics of Gly-tRNAGly and lipid intermediate II (undecaprenyl-diphospho-disaccharide-pentapeptide) were combined in a single “bi-substrate” inhibitor (IC50=56 nm). The synthetic route was exploited to generate substrates and inhibitors containing d-lactate residue (d-Lac) instead of d-Ala at the C-terminus of the pentapeptide stem, a modification responsible for vancomycin resistance in the enterococci. The substitution impaired recognition of peptidoglycan precursors by FmhB. The associated fitness cost may account for limited dissemination of vancomycin resistance genes in S. aureus.

Crystal structures of two vancomycin complexes with phosphate and N-AcetylD-Ala. structural comparison between low-affinity and high-affinity ligand complexes of vancomycin

Kikuchi, Takanori,Karki, Shyam,Fujisawa, Ikuhide,Matsushima, Yoshitaka,Nitanai, Yasushi,Aoki, Katsuyuki

experimental part, p. 391 - 400 (2010/07/08)

Crystal structures of two vancomycin complexes with phosphate and N-acetylD-Ala (AcDA) were determined. Each complex involves two crystallographically independent vancomycin molecules (V1 and V2) in the asymmetric unit, which form a usually observed back-to-back arranged vancomycin dimer V1V2 with two disaccharide chains packed in a head-to-head manner, but only one of the two ligand-binding sites is occupied. Comparison of the published crystal structures of low-affinity (small in molecular size) ligand complexes of vancomycin with high-affinity (large) ligand complexes reveals that when the high-affinity ligand binds, three structural factors (hydrogen-bonding interactions between the two peptide-backbones and hydrophobic intra-dimer sugarring and ring (face)ring (edge) interactions) work to enhance the stabilization of the back-to-back dimer-interface, an important factor that is believed to promote antibacterial activity. It has also been revealed, by examining the high-affinity ligand complexes (including N-acetylDAlaD-Ala), that sugarligand interaction could cause different affinities of the two halves of the dimer; this is a factor responsible for the failure of the ligand binding to V1 in the AcDA complex. Possible scenarios for the formation of vancomycin complexes with low-affinity as well as high-affinity ligands are presented.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 136577-07-6